(BHVN) Biohaven - Performance -51.1% in 12m
Compare BHVN with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
36.21%
#13 in Group
Rel. Strength
13.84%
#6856 in Universe
Total Return 12m
-51.06%
#99 in Group
Total Return 5y
177.26%
#8 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -31.84%
44th Percentile in Group
12m Total Return: BHVN (-51.1%) vs XBI (-14%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: BHVN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BHVN
Total Return (including Dividends) | BHVN | XBI | S&P 500 |
---|---|---|---|
1 Month | 8.41% | 2.02% | 2.87% |
3 Months | -47.08% | -15.44% | -6.42% |
12 Months | -51.06% | -14.02% | 9.87% |
5 Years | 177.26% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | BHVN | XBI | S&P 500 |
1 Month | 46.8% | 57% | 89.4% |
3 Months | -86.8% | -82.3% | -72% |
12 Months | -27.5% | -53.1% | 49.3% |
5 Years | 69.1% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #141 | 6.27% | 5.39% |
3 Month | #168 | -37.4% | -43.5% |
12 Month | #98 | -43.1% | -55.5% |
5 Years | #12 | 178% | 74.5% |
FAQs
Does BHVN Biohaven outperforms the market?
No,
over the last 12 months BHVN made -51.06%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months BHVN made -47.08%, while XBI made -15.44%.
Over the last 3 months BHVN made -47.08%, while XBI made -15.44%.
Performance Comparison BHVN vs Indeces and Sectors
BHVN vs. Indices BHVN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -11.0% | 5.54% | -56.3% | -60.9% |
US NASDAQ 100 | QQQ | -11.2% | 3.70% | -56.7% | -62.4% |
US Dow Jones Industrial 30 | DIA | -11.3% | 6.80% | -55.2% | -57.4% |
German DAX 40 | DAX | -13.1% | -10.9% | -81.8% | -76.1% |
Shanghai Shenzhen CSI 300 | CSI 300 | -11.7% | 2.14% | -55.5% | -56.7% |
Hongkong Hang Seng | HSI | -14.5% | -7.80% | -65.7% | -63.2% |
India NIFTY 50 | INDA | -8.60% | 6.13% | -58.2% | -53.4% |
Brasil Bovespa | EWZ | -13.0% | -3.12% | -65.5% | -44.6% |
BHVN vs. Sectors BHVN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -11.2% | 4.74% | -62.4% | -71.4% |
Consumer Discretionary | XLY | -11.9% | 4.90% | -54.1% | -65.1% |
Consumer Staples | XLP | -10.6% | 6.39% | -63.2% | -58.6% |
Energy | XLE | -12.0% | 8.33% | -50.3% | -41.3% |
Financial | XLF | -11.6% | 2.84% | -62.1% | -72.6% |
Health Care | XLV | -7.20% | 12.8% | -51.0% | -45.1% |
Industrial | XLI | -12.6% | 1.03% | -57.2% | -61.1% |
Materials | XLB | -11.0% | 3.70% | -52.2% | -45.0% |
Real Estate | XLRE | -10.7% | 2.29% | -58.6% | -64.5% |
Technology | XLK | -11.9% | 1.67% | -54.0% | -58.1% |
Utilities | XLU | -12.0% | 2.79% | -64.0% | -67.0% |
Aerospace & Defense | XAR | -11.5% | -0.93% | -65.6% | -76.2% |
Biotech | XBI | -2.91% | 6.39% | -35.2% | -37.0% |
Homebuilder | XHB | -10.6% | 5.34% | -42.6% | -41.3% |
Retail | XRT | -11.1% | 4.82% | -50.0% | -46.7% |